Adding mitomycin to Bacillus Calmette-Guerin as adjuvant intravesical therapy for high-risk, nonmuscle-invasive urothelial bladder cancer (BCGMM; ANZUP 1301)

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

1 Citation (Web of Science)
Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Issue number6
Publication statusPublished - 20 Feb 2020
EventGenitourinary Cancers Symposium of the American Society of Clinical Oncology (ASCO) - San Francisco, United States
Duration: 13 Feb 202015 Feb 2020

Cite this